Publication:
Reversible posterior leukoencephalopathy induced by cancer chemotherapy

Placeholder

Organizational Units

Authors

Baytan, Birol
Özdemir, Özlem
Demirkaya, Metin
Evim, Melike Sezgin
Güneş, Adalet Meral

Authors

Advisor

Language

Publisher:

Elsevier Science

Journal Title

Journal ISSN

Volume Title

Abstract

Reversible posterior leukoencephalopathy, defined by both clinical and neuroimaging findings, can affect children receiving chemotherapy. The syndrome is characterized by hypertension, alterations in mental status, seizures, hallucinations, and acute visual changes and is associated with abnormalities seen in magnetic resonance imaging of symmetric white matter lesions, especially in the parietal and occipital lobes. The etiology of reversible posterior leukoencephalopathy is as yet unknown. Presented here are four cases of reversible posterior leukoencephalopathy induced by chemotherapy, with a brief review of the literature and consideration of possible mechanisms. A diagnosis of reversible posterior leukoencephalopathy should be considered when patients receiving cancer chemotherapy suddenly develop hypertension followed by neurologic complications, especially if presenting with seizures.

Description

Source:

Keywords:

Keywords

Acute lymphoplastic-leukemia, Encephalopathy syndrome, Cortical blindness, Children, Therapy, Neurosciences & neurology, Pediatrics

Citation

Baytan, B. vd. (2010). "Reversible posterior leukoencephalopathy induced by cancer chemotherapy". Pediatric Neurology, 43(3), 197-201.

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads